TD Waterhouse Canada’s Bionano Genomics BNGO Stock Holding History

TD Waterhouse Canada’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6	Hold	5	–	–	﹤0.01%	2384
2026 Q1	$6	Buy	5 +1	+25%	+$1	﹤0.01%	2290
2025 Q4	$6	Hold	4	–	–	﹤0.01%	2026
2025 Q3	$7	Hold	4	–	–	﹤0.01%	2050
2025 Q2	$13	Hold	4	–	–	﹤0.01%	1967
2025 Q1	$12	Sell	4 -4	-50%	-$26	﹤0.01%	1925
2024 Q4	$145	Hold	8	–	–	﹤0.01%	1870
2024 Q3	$192	Hold	8	–	–	﹤0.01%	1797
2024 Q2	$308	Buy	+8	New	+$440	﹤0.01%	1799
2024 Q1	–	Sell	-8	Closed	-$797	–	1790
2023 Q4	$797	Hold	8	–	–	﹤0.01%	1570
2023 Q3	$1.33K	Hold	8	–	–	﹤0.01%	1531
2023 Q2	$2.77K	Hold	8	–	–	﹤0.01%	1496
2023 Q1	$4.92K	Hold	8	–	–	﹤0.01%	1374
2022 Q4	$6.47K	Hold	8	–	–	﹤0.01%	1295
2022 Q3	$8.2K	Hold	8	–	–	﹤0.01%	1266
2022 Q2	$6.1K	Hold	8	–	–	﹤0.01%	1343
2022 Q1	$12.1K	Hold	8	–	–	﹤0.01%	1283
2021 Q4	$14.2K	Buy	+8	New	+$21.4K	﹤0.01%	1275

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CWP

Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Waterhouse Canada's BNGO Position: Q2 2026 in Review

TD Waterhouse Canada held its Bionano Genomics (BNGO) position steady in Q2 2026 at 5 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #2384.

TD Waterhouse Canada first reported a position in BNGO in Q4 2021 and has held it in 18 quarters since. The position peaked at $14.2K in Q4 2021. 9 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

TD Waterhouse Canada held 5 shares of Bionano Genomics worth $6 as of Q2 2026.
TD Waterhouse Canada left its Bionano Genomics share count unchanged in Q2 2026.
Bionano Genomics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2384 holding.
TD Waterhouse Canada first reported a position in Bionano Genomics in Q4 2021 and has held it in 18 quarters since.
TD Waterhouse Canada's Bionano Genomics position peaked at $14.2K in Q4 2021.
9 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.